Endocannabinoid System Research: Evidence-Based Cannabis Care in Family Medicine
This study evaluates a peer-supported mental health app designed to improve outcomes in university students. The app integrates evidence-based cannabis care principles within digital mental health interventions. Results suggest modest improvements in…
United States DEA Cannabis-Related Documents Overview
Cannabis-related regulatory documents published by the DEA provide essential guidance on federal scheduling and enforcement. These documents clarify the classification of marijuana and hemp-derived cannabinoids under the Controlled Substances Act.…
D.C. Tightens Cannabis Ads While Virginia Advances Adult-Use Sales
DMV cannabis reform updates highlight D.C.'s new advertising restrictions aimed at limiting youth exposure. Virginia is progressing with its adult-use cannabis sales framework, set to launch in November 2026. These changes mark significant developments…
Cannabis Rescheduling Update: Advocates Eye AG Bondi Hearing for Status Report
Cannabis rescheduling update highlights potential easing of research restrictions and tax burdens. Advocates closely watch Attorney General Pam Bondi's hearing for status. This update clarifies that only Congress can legalize recreational marijuana.
FDA Misses Deadline to Publish Cannabinoid Classification Lists
The FDA missed the cannabinoid classification deadline mandated by Congress, creating uncertainty for hemp CBD products. This delay impacts compliance with the upcoming 2026 hemp ban. Stakeholders urge Congress to reconsider the timeline due to this…